Biomarkers for the identification of precursor polyps of colorectal serrated adenocarcinomas

[1]  N. Shepherd,et al.  UK guidance for the pathological reporting of serrated lesions of the colorectum , 2015, Journal of Clinical Pathology.

[2]  K. Klein,et al.  A clinicopathological and molecular analysis of 200 traditional serrated adenomas , 2015, Modern Pathology.

[3]  S. Serra,et al.  Histological overlap between colorectal villous/tubulovillous and traditional serrated adenomas , 2015, Histopathology.

[4]  Tsuyoshi Saito,et al.  Distinct profile of HIF1α, PTCH, EphB2, or DNA repair protein expression and BRAF mutation in colorectal serrated adenoma , 2014, Journal of gastroenterology and hepatology.

[5]  J. Hamada,et al.  Fascin regulates chronic inflammation‐related human colon carcinogenesis by inhibiting cell anoikis , 2014, Proteomics.

[6]  S. Jang,et al.  Traditional serrated adenoma of the colorectum: clinicopathologic implications and endoscopic findings of the precursor lesions. , 2013, American journal of clinical pathology.

[7]  J. Potter,et al.  Genomic aberrations occurring in subsets of serrated colorectal lesions but not conventional adenomas. , 2013, Cancer research.

[8]  B. Leggett,et al.  The serrated pathway to colorectal carcinoma: current concepts and challenges , 2013, Histopathology.

[9]  A. Conesa,et al.  Expression profiling shows differential molecular pathways and provides potential new diagnostic biomarkers for colorectal serrated adenocarcinoma , 2013, International journal of cancer.

[10]  P. Conesa‐Zamora,et al.  Colorectal serrated adenocarcinoma shows a different profile of oncogene mutations, MSI status and DNA repair protein expression compared to conventional and sporadic MSI‐H carcinomas , 2012, International journal of cancer.

[11]  Charles J. Kahi,et al.  Serrated Lesions of the Colorectum: Review and Recommendations From an Expert Panel , 2012, The American Journal of Gastroenterology.

[12]  P. Conesa‐Zamora,et al.  Immunohistochemical expression profile of β-catenin, E-cadherin, P-cadherin, laminin-5γ2 chain, and SMAD4 in colorectal serrated adenocarcinoma. , 2012, Human pathology.

[13]  P. Conesa‐Zamora,et al.  Tumour budding and other prognostic pathological features at invasive margins in serrated colorectal adenocarcinoma: a comparative study with conventional carcinoma , 2011, Histopathology.

[14]  H. Friess,et al.  Reduced α-dystroglycan expression correlates with shortened patient survival in pancreatic cancer. , 2011, The Journal of surgical research.

[15]  P. Conesa‐Zamora,et al.  Clinicopathologic study of 85 colorectal serrated adenocarcinomas: further insights into the full recognition of a new subset of colorectal carcinoma. , 2010, Human pathology.

[16]  W. Frankel,et al.  Colorectal Cancer Due to Deficiency in DNA Mismatch Repair Function: A Review , 2009, Advances in anatomic pathology.

[17]  D. Qualtrough,et al.  The actin-bundling protein fascin is overexpressed in colorectal adenomas and promotes motility in adenoma cells in vitro , 2009, British Journal of Cancer.

[18]  J. Parfitt,et al.  Survivin and hedgehog protein expression in serrated colorectal polyps: an immunohistochemical study. , 2007, Human pathology.

[19]  L. Aaltonen,et al.  Serrated carcinomas form a subclass of colorectal cancer with distinct molecular basis , 2007, Oncogene.

[20]  M. Mäkinen,et al.  Colorectal serrated adenocarcinoma , 2007, Histopathology.

[21]  M. O'brien,et al.  Comparison of Microsatellite Instability, CpG Island Methylation Phenotype, BRAF and KRAS Status in Serrated Polyps and Traditional Adenomas Indicates Separate Pathways to Distinct Colorectal Carcinoma End Points , 2006, The American journal of surgical pathology.

[22]  Robert H Fletcher,et al.  Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. , 2006, CA: a cancer journal for clinicians.

[23]  Jiafu Ji,et al.  Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumours. , 2006, Carcinogenesis.

[24]  J. Jass,et al.  Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a ‘fusion’ pathway to colorectal cancer , 2006, Histopathology.

[25]  A. Liakka,et al.  Morphology and microsatellite instability in sporadic serrated and non‐serrated colorectal cancer , 2005, The Journal of pathology.

[26]  K. Batts,et al.  Serrated polyps of the large intestine: a morphologic and molecular review of an evolving concept. , 2005, American journal of clinical pathology.

[27]  M. Mäkinen,et al.  The risk of metachronous neoplasia in patients with serrated adenoma. , 2005, American journal of clinical pathology.

[28]  P. Isaacson,et al.  Immunoproliferative small-intestinal disease. An immunohistochemical study. , 1989, The American journal of surgical pathology.

[29]  D. Lam-Himlin,et al.  Serrated Lesions of the Colorectum: Review and Recommendations From an Expert Panel , 2013 .

[30]  F. Bosman,et al.  WHO Classification of Tumours of the Digestive System , 2010 .

[31]  R. Crystal,et al.  Current Concepts and Challenges , 2008 .

[32]  N. Tallada,et al.  An Immunohistochemical Study , 1992 .

[33]  Robert C. Wolpert,et al.  A Review of the , 1985 .